AroCell AB (publ) 80R.F Stock
AroCell AB (publ) Price Chart
AroCell AB (publ) 80R.F Financial and Trading Overview
| AroCell AB (publ) stock price | 0.02 EUR |
| Previous Close | 0.04 EUR |
| Open | 0.03 EUR |
| Bid | 0.05 EUR x 0 |
| Ask | 0.07 EUR x 0 |
| Day's Range | 0.03 - 0.04 EUR |
| 52 Week Range | 0.03 - 0.07 EUR |
| Volume | 100 EUR |
| Avg. Volume | 0 EUR |
| Market Cap | 10.56M EUR |
| Beta (5Y Monthly) | 1.51226 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.02 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
80R.F Valuation Measures
| Enterprise Value | 8.89M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
AroCell AB (publ) Stock Price History
| Beta (5Y Monthly) | 1.51226 |
| 52-Week Change | 2.63% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.07 EUR |
| 52 Week Low | 0.03 EUR |
| 50-Day Moving Average | 0.05 EUR |
| 200-Day Moving Average | 0.05 EUR |
80R.F Share Statistics
| Avg. Volume (3 month) | 0 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 230.36M |
| Float | 193.52M |
| Short Ratio | N/A |
| % Held by Insiders | 41.58% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -141.93% |
| Operating Margin (ttm) | 0% |
| Gross Margin | -2.24% |
| EBITDA Margin | -30.70% |
Management Effectiveness
| Return on Assets (ttm) | -14.077% |
| Return on Equity (ttm) | -23.51% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | 42.29% |
| Gross Profit (ttm) | -2105000 EUR |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | -0.02 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 6.619 |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of AroCell AB (publ)
| Country | Germany |
| State | N/A |
| City | Uppsala |
| Address | Uppsala Business Park |
| ZIP | 754 50 |
| Phone | 46 18 50 30 20 |
| Website | https://www.arocell.com |
| Industry | Diagnostics & Research |
| Sector(s) | Healthcare |
| Full Time Employees | 26 |
AroCell AB (publ), a vitro diagnostics company, focuses on monitoring of hematological malignancies, breast cancer, and other solid tumors. The company develops, manufactures, and sells AroCell TK 210 ELISA, an immunoassay kit for the determination of Thymidine Kinase 1 in human blood. It also offers TUBEX TF, a bacteriological rapid test for diagnosis of typhoid fever. The company was formerly known as Xi Bao Research AB and changed its name to AroCell AB (publ) in 2006. AroCell AB (publ) was incorporated in 2000 and is based in Uppsala, Sweden.
Q&A For AroCell AB (publ) Stock
What is a current 80R.F stock price?
AroCell AB (publ) 80R.F stock price today per share is 0.02 EUR.
How to purchase AroCell AB (publ) stock?
You can buy 80R.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for AroCell AB (publ)?
The stock symbol or ticker of AroCell AB (publ) is 80R.F.
Which industry does the AroCell AB (publ) company belong to?
The AroCell AB (publ) industry is Diagnostics & Research.
How many shares does AroCell AB (publ) have in circulation?
The max supply of AroCell AB (publ) shares is 317.46M.
What is AroCell AB (publ) Price to Earnings Ratio (PE Ratio)?
AroCell AB (publ) PE Ratio is now.
What was AroCell AB (publ) earnings per share over the trailing 12 months (TTM)?
AroCell AB (publ) EPS is -0.02 EUR over the trailing 12 months.
Which sector does the AroCell AB (publ) company belong to?
The AroCell AB (publ) sector is Healthcare.